sphingotec GmbH
Hennigsdorf, DE · Founded 2002 · 20 employees on LinkedIn · 1 known investors
SphingoTec develops proprietary biomarkers for critical care diagnostics, addressing acute kidney injury, sepsis, and acute heart failure through partnerships with in vitro diagnostics companies and pharmaceutical firms. The company licenses its biomarker portfolio to global IVD partners to make clinical diagnostic products available worldwide.
Founders & leadership
DB
Deborah BergmannChief Executive Officer
Investors · 1
In the news
Frequently asked questions
- What does sphingotec GmbH do?
- SphingoTec develops proprietary biomarkers for critical care diagnostics, addressing acute kidney injury, sepsis, and acute heart failure through partnerships with in vitro diagnostics companies and pharmaceutical firms. The company licenses its biomarker portfolio to global IVD partners to make clinical diagnostic products available worldwide.
- Who are sphingotec GmbH's investors?
- sphingotec GmbH's investors include Brandenburg Kapital.
- Where is sphingotec GmbH headquartered?
- sphingotec GmbH is headquartered in Hennigsdorf, DE.